
Healthcare
Seattle-based healthcare company Atossa Genetics Inc. (NASDAQ:ATOS) has announced that they have received approval from the Swedish Medical Products Agency (MPA) to move on to Phase 2 of their treatment of women with mammographic breast ... [Read]